US2016338993A1PendingUtilityA1
Wound healing
Est. expiryMay 21, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61K 31/355A61K 31/198A61L 26/0066A61L 2300/412A61L 15/44A61K 45/06A61K 9/0014
36
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating a chronic wound in a subject in need of such treatment is provided. The method includes administering to the subject at least one antioxidant agent in an amount effective to treat the wound. In some versions, the antioxidant agent is α-tocopherol or N-acetyl cysteine, or a combination of these compounds.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a chronic wound in a subject in need thereof, comprising administering to the subject at least one antioxidant agent in an amount effective to treat the wound.
2 . The method of claim 1 , wherein the at least one antioxidant agent is two or more antioxidant agents.
3 . The method of claim 1 , wherein the at least one antioxidant agent is a free radical scavenger, a lipid peroxidation inhibitor, or a combination thereof.
4 . The method of claim 1 , wherein the at least one antioxidant agent comprises N-acetyl cysteine, vitamin A, vitamin C, vitamin E, glutathione, lipoic acid, carotenes, coenzyme Q (ubiquinol), melatonin, ellagic acid, punicic acid, luteolin, catalase, superoxide dismutase, peroxiredoxins, cysteine, flavenoids, phenolics, ergothioneine, a physiological salt thereof, or any combination thereof.
5 . The method of claim 1 , wherein the at least one antioxidant agent comprises α-tocopherol, N-acetyl cysteine, a physiological salt thereof, or any combination thereof.
6 . The method of claim 1 , wherein the chronic wound is a frankly chronic wound.
7 . The method of claim 6 , wherein the frankly chronic wound contains exudate.
8 . The method of claim 1 , wherein the treating comprises dismantling of the biofilm, improvement in the re-epithelialization of the wound, improvement in maturity of the granulation tissue of the wound, decrease in wound infection, resolution of inflammation, increase in rate of wound healing, establishment of homeostasis, or any combination thereof.
9 . The method of claim 1 , wherein the subject is a human or animal.
10 . The method of claim 9 , wherein the subject is a diabetic.
11 . The method of claim 1 , wherein the wound is treated by debridement before administering at least one antioxidant agent.Join the waitlist — get patent alerts
Track US2016338993A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.